These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3552340)

  • 1. Functional effects of epidermal cell culture supernatants (ECCS) on human B-cell activation.
    Penso D; Faure M; Delfraissay JF; Wallon C; Vazquez A; Thivolet J; Galanaud P
    Clin Immunol Immunopathol; 1987 May; 43(2):163-73. PubMed ID: 3552340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
    Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
    Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulation in the rat: cellular and molecular requirements for B cell responses to types 1, 2, and T-dependent antigens.
    Eldridge JH; Kimura S; Morisaki I; Michalek SM; Hamaoka T; Hamada S; McGhee JR
    J Immunol; 1985 Apr; 134(4):2236-46. PubMed ID: 2857748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a major 50-kDa molecular weight human B-cell growth factor with Tac antigen-inducing activity on B cells.
    Kawano M; Matsushima K; Oppenheim JJ
    Cell Immunol; 1987 Aug; 108(1):132-49. PubMed ID: 3111722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of B-cell growth factor receptor reactivity in healthy donors and in patients with chronic lymphatic leukemia: relationship to B-cell-derived lymphokines.
    Benjamin D; Bazar LS; Wallace B; Jacobson RJ
    Cell Immunol; 1986 Dec; 103(2):394-408. PubMed ID: 3100061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation factors for human specific B cell response.
    Vazquez A; Gerard JP; Delfraissy JF; Dugas B; Auffredou MT; Crevon MC; Fradelizi D; Galanaud P
    Eur J Immunol; 1986 Jul; 16(7):803-8. PubMed ID: 3487460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characterization of a human B cell line utilizable for the assay of B cell growth factors.
    Warrington RJ
    J Immunol Methods; 1987 Jun; 100(1-2):117-22. PubMed ID: 3110293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation.
    Weiss L; Delfraissy JF; Vazquez A; Wallon C; Galanaud P; Kazatchkine MD
    J Immunol; 1987 May; 138(9):2988-93. PubMed ID: 2952731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 1 can replace monocytes for the specific human B-cell response to a particulate antigen.
    Vazquez A; Balavoine JF; Delfraissy JF; Wakasugi H; Galanaud P
    Cell Immunol; 1984 Jul; 86(2):287-98. PubMed ID: 6610477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity.
    Chatenoud L; Dugas B; Beaurain G; Touam M; Drueke T; Vasquez A; Galanaud P; Bach JF; Delfraissy JF
    Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7457-61. PubMed ID: 3094009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different reactivity of activated human B cells to B-cell growth factor and interleukin 2 in the costimulation assay with anti-IgM antibody and in the preactivation assay with Staphylococcus bacteria.
    Almerigogna F; Biagiotti R; Giudizi GM; Del Prete GF; Maggi E; Mazzetti M; Alessi A; Ricci M; Romagnani S
    Cell Immunol; 1985 Oct; 95(2):358-67. PubMed ID: 3876163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF).
    Procopio AD; Allavena P; Ortaldo JR
    J Immunol; 1985 Nov; 135(5):3264-71. PubMed ID: 3876382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
    Kawano M; Iwato K; Kuramoto A
    J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF).
    Vazquez A; Gérard JP; Olive D; Auffredou MT; Dugas B; Karray S; Delfraissy JF; Galanaud P
    Eur J Immunol; 1986 Dec; 16(12):1503-7. PubMed ID: 3102243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct culture requirements for activation and proliferation of human peripheral blood B lymphocytes by Staphylococcus aureus Cowan strain and growth factors.
    Choi YS; Xia X
    J Immunol Methods; 1987 Jul; 101(1):29-36. PubMed ID: 3112237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies of the mechanisms of human B cell activation. I. Development of an assay system for human B cell growth factors (BCGF) and identification of BCGF-producing T cell subsets].
    Ueda Y; Sakane T; Suzuki N; Takada S; Murakawa Y; Tsunematsu T; Niwa Y; Tsuchiya T
    Arerugi; 1984 Oct; 33(10):859-67. PubMed ID: 6335391
    [No Abstract]   [Full Text] [Related]  

  • 19. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2.
    Hivroz C; Grillot-Courvalin C; Brouet JC; Seligmann M
    Eur J Immunol; 1986 Aug; 16(8):1001-4. PubMed ID: 3488907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular interaction between B and T lymphocytes: enhanced release of B cell growth factor.
    Mehta SR; Sandler RS; Ford RJ; Sharma S; Maizel AL
    Lymphokine Res; 1986; 5(1):49-57. PubMed ID: 3484798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.